{"favorite_id": 10070, "calc_type": "", "dosing": false, "full_title_en": "ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC)", "short_title_en": "ALBI Grade for HCC", "medium_description_en": "<span id=\"docs-internal-guid-7b66b5af-facb-4f1a-50cb-ad20b021bca4\">Predicts survival in HCC patients.</span>", "short_description_en": "HCC survival.", "before_use": "", "instructions_en": "", "purpose_en": ["Prognosis"], "disease_en": ["Hepatocellular Carcinoma"], "specialty_en": ["Hepatology", "Hematology and Oncology", "Hospitalist Medicine", "Internal Medicine", "Gastroenterology"], "chief_complaint_en": ["Jaundice", "Abdominal Pain"], "system_en": ["Oncologic", "Gastrointestinal"], "search_abbreviation_en": ["Albi score"], "slug": "albi-albumin-bilirubin-grade-hepatocellular-carcinoma-hcc", "seo": {"meta_description_en": "The ALBI (Albumin-Bilirubin) Grade for Hepatocellular Carcinoma (HCC) predicts survival in HCC patients.", "keywords_en": "Albumin, bilirubin, liver function, liver dysfunction, HCC survival, C-P grade, Child-Pugh grade"}, "content": {"how_to_use": {"use_case_en": "<p>Do you use the&nbsp;ALBI Grade for HCC and want to contribute your expertise?&nbsp;<a href=\"https://www.mdcalc.com/join-us\" target=\"_blank\">Join</a>&nbsp;our contributor team!</p>", "pearls_pitfalls_en": "", "why_use_en": ""}, "next_steps": {"advice_en": "<p>Do you use the&nbsp;ALBI Grade for HCC and want to contribute your expertise?&nbsp;<a href=\"https://www.mdcalc.com/join-us\" target=\"_blank\">Join</a>&nbsp;our contributor team!</p>", "management_en": "", "critical_actions_en": ""}, "about": {"formula_en": "<p><span id=\"docs-internal-guid-ef144afc-fad1-7c29-30ea-1de3beba1b3c\">ALBI = (log<sub>10</sub> bilirubin &times; 0.66) + (albumin &times; -0.085), where bilirubin is in &mu;mol/L and albumin in g/L.</span></p>", "more_info_en": "<p dir=\"ltr\">Interpretation:</p>\n<div dir=\"ltr\">\n<table><colgroup><col width=\"119\" /><col width=\"81\" /><col width=\"81\" /></colgroup>\n<tbody>\n<tr>\n<td>\n<p dir=\"ltr\"><strong>ALBI Score</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Grade</strong></p>\n</td>\n<td>\n<p dir=\"ltr\"><strong>Median survival</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&le;-2.60</p>\n</td>\n<td>\n<p dir=\"ltr\">1</p>\n</td>\n<td>\n<p dir=\"ltr\">18.5-85.6 months</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;-2.60 to &le;-1.39</p>\n</td>\n<td>\n<p dir=\"ltr\">2</p>\n</td>\n<td>\n<p dir=\"ltr\">5.3-46.5 months</p>\n</td>\n</tr>\n<tr>\n<td>\n<p dir=\"ltr\">&gt;-1.39</p>\n</td>\n<td>\n<p dir=\"ltr\">3</p>\n</td>\n<td>\n<p dir=\"ltr\">2.3-15.5 months</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p><span id=\"docs-internal-guid-bc764477-fad2-0cb6-687f-ab512a08816e\"></span><span id=\"docs-internal-guid-bc764477-fad2-0cb6-687f-ab512a08816e\"><br /></span></p>", "evidence_based_medicine_en": "", "references_list": {"Original/Primary Reference": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/25512453", "text": "Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550-8."}], "Other References": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/28626732", "text": "Hiraoka A, Kumada T, Kudo M, et al. Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh Classifications. Liver Cancer. 2017;6(3):204-215."}], "Validation": [{"href": "https://www.ncbi.nlm.nih.gov/pubmed/29234636 ", "text": "Hiraoka A, Michitaka K, Kumada T, et al. Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic Function. Liver Cancer. 2017;6(4):325-336."}, {"href": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5478326/", "text": "Chen B, Lin S. Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure. Medicine (Baltimore). 2017;96(24):e7142."}, {"href": "https://onlinelibrary.wiley.com/doi/full/10.1111/liv.13527", "text": "Lee PC, Chen YT, Chao Y, et al. Validation of the albumin-bilirubin grade-based integrated model as a predictor for sorafenib-failed hepatocellular carcinoma. Liver Int. 2018;38(2):321-330."}], "Clinical Practice Guidelines": [{"href": "", "text": ""}], "Manufacturer Website": [{"href": "", "text": ""}], "Outcomes": [{"href": "", "text": ""}]}}, "contributor": {"expert_name": []}, "creator": [{"name": "Dr. Philip J. Johnson", "creator_info": {"about_en": "Philip J. Johnson, MD, FRCP, is a professor in translational oncology at the University of Liverpool. He is also the deputy director of the North West Cancer Research Centre, University of Liverpool. Dr. Johnson\u2019s primary research is focused on diagnosis and prognosis of hepatobiliary and pancreatic cancer.", "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-philip-j-johnson.jpg", "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Johnson+PJ%5Bau%5D"}}], "related_resources": {"mdcalc_rating": {"evidence": "", "clinical": "", "popularity": ""}, "guidelines": [], "teaching": [], "videos": [], "interests": [], "partner_contact": [], "sdm_tool": []}}, "input_schema": [{"type": "textbox", "label_en": "Bilirubin", "name": "bilirubin", "unit": "bili", "conditionality": "", "optional": false, "unit_info": {"name": "Bilirubin", "conversion": 17.104, "error_min": 1e-08, "error_max": 50, "warn_min": 0, "warn_max": 20, "normal_max_si": 32.49, "normal_min_si": 5.13, "normal_min_us": 0.3, "units_si": "\u00b5mol/L", "units_us": "mg/dL", "normal_max_us": 1.9}}, {"type": "textbox", "label_en": "Albumin", "name": "albumin", "unit": "alb", "conditionality": "", "optional": false, "unit_info": {"name": "Albumin", "conversion": 10, "error_min": 0, "error_max": 7, "warn_min": 1, "warn_max": 6, "normal_max_si": 55, "normal_min_si": 35, "normal_min_us": 3.5, "units_si": "g/L", "units_us": "g/dL", "normal_max_us": 5.5}}], "md5": "ed4e0a6935fb1d7592fe36e4e580c6d6", "related_calcs": [{"calcId": 10094, "short_title_en": "GALAD Model for HCC", "slug": "galad-model-hepatocellular-carcinoma-hcc"}, {"calcId": 10240, "short_title_en": "CLIF-C ACLF", "slug": "clif-c-aclf-acute-chronic-liver-failure"}, {"calcId": 10147, "short_title_en": "UKELD Score", "slug": "united-kingdom-model-end-stage-liver-disease-ukeld"}]}